Health Condition 1: D898- Other specified disorders involving the immune mechanism, not elsewhere classified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with aggressive malignant Lymphoma Stage II-IV, planned to receive chemotherapy between the age of 18-65yrs with ECOG performance score of 0-2 2. Patients willing to participate in the study, and should have access to audio-video displaying device (CD player, multimedia phone /smart phone/laptop) 3. Patients who will be able to understand English, Hindi, Punjabi
Exclusion criteria
Exclusion criteria: 1. Patients with stage I Lymphoma 2. Patients who continued to have ECOG score 3-4 even at 2nd chemotherapy cycle
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FACT Health related quality scoresTimepoint: Before start of chemotherapy, at 2nd, 4th and 6th month of chemotherapy | — |
Secondary
| Measure | Time frame |
|---|---|
| Morbidity profile: Fatigue, sleep quality, depression, anxiety and pain AdherenceTimepoint: before start of chemotherapy, 2nd, 4th and 6th month of chemotehrapy | — |
Countries
India
Contacts
PGIMER